These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25591759)

  • 1. Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway.
    Dong J; Lin J; Wang B; He S; Wu C; Kushwaha KK; Mohabeer N; Su Y; Fang H; Huang K; Li D
    Cell Physiol Biochem; 2015; 35(1):160-74. PubMed ID: 25591759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome.
    Wang B; Peng Y; Dong J; Lin J; Wu C; Su Y; Fang H; Wang L; Huang K; Li D
    Cell Physiol Biochem; 2013; 32(6):1741-50. PubMed ID: 24356513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor.
    Mao Y; Peng Y; Zeng Q; Cheng L; Wang B; Mao X; Meng K; Liu Y; Lian Y; Li D
    PLoS One; 2015; 10(10):e0141464. PubMed ID: 26517374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
    Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
    Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway.
    Li S; Yi Z; Deng M; Scott MJ; Yang C; Li W; Lei Z; Santerre NM; Loughran P; Billiar TR
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSLP/TSLPR promote angiogenesis following ischemic stroke via activation of the PI3K/AKT pathway.
    Yu X; Peng Y; Liang H; Fu K; Zhao Z; Xie C; Zhou L; Zhang K
    Mol Med Rep; 2018 Feb; 17(2):3411-3417. PubMed ID: 29257253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B.
    Lova P; Paganini S; Hirsch E; Barberis L; Wymann M; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2003 Jan; 278(1):131-8. PubMed ID: 12407113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
    Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
    Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
    PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-induced Akt activation--regulation and possible function.
    Reséndiz JC; Kroll MH; Lassila R
    J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
    Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.
    Pan G; Liang Y; Lu L; Chen X; Wang M; Wang L; Yan C; Zhang W
    Int J Clin Exp Pathol; 2015; 8(9):10698-706. PubMed ID: 26617780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
    Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
    Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSLP protects against sepsis-induced liver injury by inducing autophagy via activation of the PI3K/Akt/STAT3 pathway.
    Wang H; Zhu J; Wei L; Wu S; Shang L; Ye X; Li S
    Pathol Res Pract; 2022 Aug; 236():153979. PubMed ID: 35751928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A platelet biomarker for assessing phosphoinositide 3-kinase inhibition during cancer chemotherapy.
    Bowers RK; Marder P; Green LJ; Horn CL; Faber AL; Thomas JE
    Mol Cancer Ther; 2007 Sep; 6(9):2600-7. PubMed ID: 17766838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
    Kauffenstein G; Bergmeier W; Eckly A; Ohlmann P; Léon C; Cazenave JP; Nieswandt B; Gachet C
    FEBS Lett; 2001 Sep; 505(2):281-90. PubMed ID: 11566191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.